Shanghai 7th People's Hospital
10
3
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
CGM for Insulin-Treated T2DM During Post-Discharge Transition
Role: collaborator
Ning Shen Dan Xiang Gao Fang for Heart-Kidney Disharmony Insomnia
Role: lead
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
Role: collaborator
Acupuncture and Escitalopram for Treating Major Depression Clinical Study
Role: lead
Biomarkers Based EArly Diagnosis of STroke Subtype Cohort（Bio-EAST）
Role: collaborator
Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
Role: collaborator
A Prospective Multi-Center Real-World Study of Ciwujia Capsules in the Treatment of Cancer-Related Insomnia
Role: collaborator
One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China
Role: collaborator
The Selection of Pregnancy for Patients After Tubal Ectopic Pregnancy Treatment
Role: collaborator
The Efficacy of the Traditional Chinese Medicine Niubang Pill Combined With Methotrexate on Active Rheumatoid Arthritis
Role: collaborator
All 10 trials loaded